Business Context and Reporting Period
This Form 8-K Current Report was filed by WellPoint, Inc. (now Elevance Health, Inc.) on December 30, 2005, reporting an event that occurred on December 28, 2005. The filing discloses the entry into a material definitive agreement: a new employment contract with Larry C. Glasscock, the Company's President and Chief Executive Officer.
Key Financial Metrics
The filing does not provide general financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the compensation structure and terms of the CEO's employment agreement.
- Annual Base Salary: $1,250,000
- Target Incentive Bonus: 125% of base salary ($1,562,500)
- Legal Fee Reimbursement: Up to $125,000 plus tax gross-up
- Severance (Termination without cause/Good Reason): 3x sum of annual base salary and target bonus, paid over three years (or lump sum if Change in Control occurs)
- Post-Termination Office Support Stipend: $95,000 per year for two years
Material Changes Versus Prior Period
The primary material change is the execution of a new employment agreement replacing the prior contract which expired on December 31, 2005. Key changes include:
- Term Extension: The new agreement establishes an initial term expiring December 31, 2008, with automatic one-day extensions thereafter to maintain a minimum one-year remaining term, subject to notice provisions and a cap at the CEO's 62nd birthday.
- Role Expansion: The agreement formalizes Mr. Glasscock's role as a member of the Board of Directors and Chairman of the Board during the term.
- Retirement Benefits: Introduction of a "replacement ratio SERP benefit" calculated as a lump sum based on final average pay, with specific accrual rates and offsets against other pension plans.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The filing contains no financial guidance or strategic outlook beyond the retention of current leadership through 2008 and beyond.
Risks and Contingencies:
- Forfeiture Clauses: Significant portions of the SERP benefit and severance are forfeitable if the CEO is terminated for "cause" or willfully breaches restrictive covenants (non-compete, non-solicit, confidentiality).
- Excise Tax Gross-Up: The Company is obligated to provide gross-up payments to cover any excise tax imposed under Section 4999 of the Internal Revenue Code on payments exceeding certain thresholds.
- Equity Vesting: In the event of termination without cause, for good reason, death, disability, or retirement, all outstanding equity awards become fully vested and non-forfeitable.
Important Facts for Investor Verification
- Verify the total potential cash and equity payout obligations in the event of a Change in Control followed by termination.
- Confirm the specific definitions of "cause" and "good reason" within the agreement to understand the conditions under which severance is triggered.
- Assess the impact of the SERP benefit accrual (7.5% annual increase) on the Company's long-term liability.
- Note that the filing does not disclose the Company's current financial health; investors should refer to the most recent 10-K or 10-Q for liquidity and solvency data.